Perrigo | PRGO - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
AbbVie USD 3.84B 205M 2026-09
Abbott USD 4.27B 669M 2026-09
Bayer EUR 4.02B 53M 2026-09
Bristol-Myers Squibb USD 1.7B 127M 2026-09
Coherus Biosciences USD 15M 6.26M 2025-12
Corcept Therapeutics USD 142.04M 14.86M 2026-09
Dr.Reddys Laboratories INR 26.1B 11.63B 2026-06
Eli Lilly USD 3.12B 305M 2026-09
J&J USD 6.25B 168M 2026-09
Merck USD 2.86B 25M 2026-09
Nestle CHF 12.33B 133M 2026-06
Pacira USD 950.8M 858.99M 2026-09
Perrigo USD 271.7M 3.01B 2026-09
Pfizer USD 3.28B 132M 2026-09
Phibro Animal Health USD 78.32M 10.24M 2025-12
Prestige Brands USD 2.08B 2.04B 2026-09
Sanofi EUR 2.31B 325M 2026-09
Supernus Pharmaceuticals USD 133.64M 15.41M 2026-06
Teva Pharmaceutical Industries USD 1.01B 27M 2026-09
Xeris Pharmaceuticals USD 61.04M 7.89M 2026-06
Zoetis USD 582M 10M 2026-09